Phase II Pilot Study of Brentuximab Vedotin, Rituximab and Dose Attenuated CHP in Elderly Patients With DLBCL
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Brentuximab vedotin (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- Sponsors Seattle Genetics
- 11 Nov 2016 Planned End Date changed from 1 Apr 2020 to 1 Jun 2020.
- 11 Nov 2016 Planned primary completion date changed from 1 Apr 2018 to 1 Jun 2018.
- 11 Nov 2016 Status changed from not yet recruiting to recruiting.